Navigation Links
ev3 Inc. Accepts Resignation of Dr. John Simpson
Date:2/8/2008

PLYMOUTH, Minn., Feb. 8 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV), a global endovascular device company, today announced the resignation of Dr. John Simpson from his position as Chief Scientist and from the company's board of directors effective February 7, 2008.

"Over the last thirty years, few people have shaped the treatment of cardiovascular disease as much as Dr. John Simpson with his numerous inventions and vision for improving the lives of patients worldwide," said Jim Corbett, chairman, president and chief executive officer of ev3 Inc. "He leaves a legacy of innovation and a foundation on which we intend to build in our effort to improve patient treatment."

With the resignation of Dr. Simpson, the ev3 board of directors has nine members, of which six are independent directors.

About ev3 Inc.

Since its founding in 2000, ev3 has been dedicated to improving the lives of patients with vascular disease through the development of innovative endovascular therapies. ev3's products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today - peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolic coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net.

ev3, the ev3 logo and FoxHollow are trademarks of ev3 Inc., registered in the U.S. and other countries. All trademarks and trade names referred to in this press release are the property of their respective owners.


'/>"/>
SOURCE ev3 Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
2. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
3. American Stock Exchange Accepts Encisions Plan to Regain Compliance
4. Governor Rendell Accepts National Health Care Reform Pioneer Award
5. FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
6. Lieutenant Governor Catherine Baker Knoll Accepts Women in Government Presidential Leadership Award
7. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
8. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
9. Aflac Announces Resignation of U.S. Marketing Officer
10. Genta Announces Resignation of Dr. Betsy McCaughey from Board of Directors
11. Protalix BioTherapeutics Announces Resignation of Board Members

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...AS, Nov. 27 Considered ... only 25 years ago, solid organ transplantation is...the extraordinary men and women who gathered at th...rs came together from medical centers around the w...egional Transplant Institute (BRTI), one of the pi...
(Date:11/27/2009)... XenaCare Holdings has announced that it ...ndation, one of the largest nonprofit organization...h education. , Delray Bea...ngs, Inc. (OTCBB: XCHO), a company specializing in... healthcare products, has announced today that is ...
(Date:11/27/2009)... Multi-purpose bilingual coloring books d...e by the business community to educate - inform pa...from Safety issues to Dinosuars to ABC,S and a hos...t Louis, MO (PRWEB) November 27, 2009 -- Today&rsq...toys to keep them busy any hour of the day, but on...
(Date:11/26/2009)... years, the number of Americans living with diabet...n in 2009 to 44.1 million in 2034. Over the same p...sing from $113 billion to $336 billion, even with ...ers based at the University of Chicago report in t...er of those with diabetes covered by Medicare will...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Cen...allas , is one of a growing number of physicians w...ing sites to connect with individuals who are inte...morbid obesity. Dr. Kim is utilizing Facebook to s... his practice with the community. , ...
Breaking Medicine News(10 mins):Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3
... of universal CRT replacements for MRI, CT, US, NM... medical devices is now available from Medical Dis...ters can now extend equipment ROI and lower replac...ba, Hitachi, Shimadzu, Picker, and many more medic...
...convened by the Christian anti-hunger advocacy gro... to pass the Initiating Foreign Assistance Reform ...s the process of overhauling U.S. foreign assistan...b possible of helping hungry and poor people aroun...
...o air on the Big Ten Network , , UNIVERSITY PARK,... modern warfare. "Emotionless warriors" and though...ture. What are the medical and ethical ramificatio...er Patty Satalia, offers thoughtful, in-depth exch...
...celebrity has the best butt? The most awesome abs?... here! , , eDiets.com (Nasdaq: DIET ) asked ove...s, sports figures and singers to help us determine...If you want to achieve your best body, visit eDie...
...iance on Mental Illness (NAMI) honored 41 doctors ...iatric Association (APA) annual conference in San ...ychiatrists from across the country for their exce...r support of individuals and families, mental heal...
... shows promise , , TUESDAY, May 19 (Heal...ve the effectiveness of antibiotics by allowing th...earch suggests. , A spray of antibiotics encapsula...s in tests on mice infected with Pseudomona aerog...
Other Medicine News:Health News:Universal CRT Replacement Gives New Life to Medical Equipment with Analog Video 2Health News:Universal CRT Replacement Gives New Life to Medical Equipment with Analog Video 3Health News:Church Leaders Urge U.S. Congress to Support U.S. Foreign Aid Reform Bill 2Health News:WPSU Debuts New Series; 1st Show Tackles Neuroscience and the Military 2Health News:eDiets.com Survey: And the Best Butt Award Goes To... 2Health News:NAMI Applauds America's Exemplary Psychiatrists 2Health News:NAMI Applauds America's Exemplary Psychiatrists 3
(Date:11/28/2009)...e/ -- Siemens Healthcare redefines productivity w...ging matrix) technology and with its new Dot(TM) (...es are introduced in the new MAGNETOM ® Aera...nners at the 95th Scientific Assembly and Annual M...a (RSNA) from November 29 to December 3 at McCormi...
(Date:11/26/2009)...a, Nov. 26 The 2009 Frost & Su...he Generic Pharmaceutical Market is presented to C...tp://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ...lowing criteria were used to benchmark Cipla Medpr...rategy and implementation, degree of innovation in...
(Date:11/25/2009)...Newswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: ...mmitted to discovering, developing and commerciali...ed financial results for the fiscal year ended Sep...held $58.4 million in cash, cash equivalents and s... 2009 Highlights ,, RG7128 ,, Phase 2b ...
Breaking Medicine Technology:Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10UCF researcher developing computer program to detect measure brain tumors 47652 1UCF researcher developing computer program to detect measure brain tumors 47652 2Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 1Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 2Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 3Researchers Suggest That Oxidative Stress is Strongly Evident in the In Utero Environment of the Fetus With Down Syndrome 47646 1Researchers Suggest That Oxidative Stress is Strongly Evident in the In Utero Environment of the Fetus With Down Syndrome 47646 2
...ic testing can be,used to help personalize the the...oagulant, according to research published in the,S...he American Society of,Hematology. This result rep...individual,s genetic information to guide personal...ugs differently, varying doses of,warfarin are nee...
...tudy Targets Biomarker-Defined Population, BERKEL...daq: GNTA ) announced that the first patients hav...e 3 trial of Genasense,(oblimersen sodium) Injecti...A, is a randomized, double-blind, placebo-controll...o receive Genasense plus dacarbazine (DTIC),or DTI...
Other Medicine Technology:Genetics Determine Optimal Drug Dose of Common Anticoagulant 2Genetics Determine Optimal Drug Dose of Common Anticoagulant 3Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 2Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 3Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 4Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 5
Operative Laparoscopes
Bariatric Laparoscopes
Unheated Anaerobic Chamber with Automatic Airlock - Model B
Bactron X
Medicine Products: